JP2019534006A5 - - Google Patents

Download PDF

Info

Publication number
JP2019534006A5
JP2019534006A5 JP2019522226A JP2019522226A JP2019534006A5 JP 2019534006 A5 JP2019534006 A5 JP 2019534006A5 JP 2019522226 A JP2019522226 A JP 2019522226A JP 2019522226 A JP2019522226 A JP 2019522226A JP 2019534006 A5 JP2019534006 A5 JP 2019534006A5
Authority
JP
Japan
Prior art keywords
patent document
disease
liver
vol
journal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019522226A
Other languages
English (en)
Other versions
JP7244418B2 (ja
JP2019534006A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/059860 external-priority patent/WO2018085622A1/en
Publication of JP2019534006A publication Critical patent/JP2019534006A/ja
Publication of JP2019534006A5 publication Critical patent/JP2019534006A5/ja
Priority to JP2023036651A priority Critical patent/JP7576647B2/ja
Application granted granted Critical
Publication of JP7244418B2 publication Critical patent/JP7244418B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

ヒトの肝臓は、脂質代謝、アンモニウムおよび胆汁産生、凝固、ならびに外因性化合物の解毒など、生命に不可欠な多くの代謝機能を提供する重要な臓器である。人工多能性幹細胞(iPSC)技術を使用して、患者の肝反応のインビトロ再構成は、再生療法、創薬、および薬物毒性研究を含む多数の有望な用途により、製薬業界にとって魅力的である。この目的のために、現在、従来のインビトロアプローチは、肝細胞を生成するために二次元(2−D)および3−D分化プラットフォームを研究している。しかしながら、報告された方法のほとんどは細胞を主に標的上皮細胞型に分化させ、線維化促進性および/または炎症性細胞型などの必須の支持成分を完全に欠いている。あるいは、出願人らは、上皮系列と支持系列を混合することによる共培養ベースのアプローチを提案したが、これらのアッセイは非常に可変的であり、上皮細胞培地(ECM)およびそれらを同時に維持することができる培地を選択することの困難性などの多くの人為的な変化によってしばしば混乱させられる。したがって、支持系統を疾患モデル化およびさらなるスクリーニング適用のために共同開発する、新しくて頑強なアッセイシステムの確立の必要性がある。
この出願の発明に関連する先行技術文献情報としては、以下のものがある(国際出願日以降国際段階で引用された文献及び他国に国内移行した際に引用された文献を含む)。
(先行技術文献)
(特許文献)
(特許文献1) 国際公開第2015/185714号
(非特許文献)
(非特許文献1) Gori et al."Investigating Nonalcoholic Fatty Liver Disease in a Liver−on−a−Chip Microfluidic Device",PLoS One 11(7):e0159729. Doi10.1371/journal.pone.0159729,July 20,2016.
(非特許文献2) Park et al."Lipotoxicity of Palmitic Acid on Neural Progenitor Cells and Hippocampal Neurogenesis",Toxicological Research,27(2),103:110,June 2011.
(非特許文献3) Nandivada et al."Treatment of Parenteral Nutrition−Associated Liver Disease: The Role of Lipid Emulsions",Nutr.Vol.4: 711−717,November 2013.
(非特許文献4) Cabezas et al."Nonalcoholic Fatty Liver Disease: A Pathological View",Nobumi Tagaya,ISBN 978−953−51−0853−5,November 21,2012.
(非特許文献5) Kruitwagen et al."Long−Term Adult Feline Liver Organoid Cultures for Disease Modeling of Hepatic Steatosis" Stem Cell Reports,vol.8,no.4,April 1,2017.
(非特許文献6) Kruitwagen et al."Research Communications of the 26th ECVIM−CA Congress−20160908 to 2016091−SCH−O−5 LONG−TERM ADULT FELINE LIVER ORGANOID CULTURES FOR DISEASE MODELLING OF HEPATIC LIPIDOSIS", Journal of Veterinary Internal Medicine, vol.31,no.1,January 1,2017
(非特許文献7) Mori et al."Micropatterned organoid culture of rat hepatocytes and HepG2 cells"Journal of Bioscience and Bioengineering.Vol.106,no.3,September 1,2008.
(非特許文献8) Nantasanti et al."Concise Review: Organoids Are a Powerful Tool for the Study of Liver Disease and Personalized Treatment Design in Humans and Animals: Organoids for Disease Modeling and Therapy",Stem Cells Translational Medicine,vol.5,no.3.January 21,2016.
(非特許文献9) Ricchi et al."Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes" Journal of Gastroenterology and Hepatology,vol.24,no.5,May 1,2009.
JP2019522226A 2016-11-04 2017-11-03 肝臓オルガノイド疾患モデルおよびその作製方法 Active JP7244418B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023036651A JP7576647B2 (ja) 2016-11-04 2023-03-09 肝臓オルガノイド疾患モデルおよびその作製方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662417371P 2016-11-04 2016-11-04
US62/417,371 2016-11-04
US201762517414P 2017-06-09 2017-06-09
US62/517,414 2017-06-09
PCT/US2017/059860 WO2018085622A1 (en) 2016-11-04 2017-11-03 Liver organoid disease models and methods of making and using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023036651A Division JP7576647B2 (ja) 2016-11-04 2023-03-09 肝臓オルガノイド疾患モデルおよびその作製方法

Publications (3)

Publication Number Publication Date
JP2019534006A JP2019534006A (ja) 2019-11-28
JP2019534006A5 true JP2019534006A5 (ja) 2020-10-15
JP7244418B2 JP7244418B2 (ja) 2023-03-22

Family

ID=62076362

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019522226A Active JP7244418B2 (ja) 2016-11-04 2017-11-03 肝臓オルガノイド疾患モデルおよびその作製方法
JP2019522219A Active JP7078615B2 (ja) 2016-11-04 2017-11-03 肝臓オルガノイド組成物ならびにその作製および使用方法
JP2022082075A Active JP7545186B2 (ja) 2016-11-04 2022-05-19 肝臓オルガノイド組成物ならびにその作製および使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019522219A Active JP7078615B2 (ja) 2016-11-04 2017-11-03 肝臓オルガノイド組成物ならびにその作製および使用方法
JP2022082075A Active JP7545186B2 (ja) 2016-11-04 2022-05-19 肝臓オルガノイド組成物ならびにその作製および使用方法

Country Status (11)

Country Link
US (4) US20200056157A1 (ja)
EP (3) EP3534919A4 (ja)
JP (3) JP7244418B2 (ja)
KR (2) KR102546194B1 (ja)
CN (3) CN117229994A (ja)
AU (2) AU2017353982B2 (ja)
CA (2) CA3041714A1 (ja)
IL (1) IL266398A (ja)
NZ (1) NZ753051A (ja)
SG (2) SG10202104575WA (ja)
WO (3) WO2018085615A1 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011140441A2 (en) 2010-05-06 2011-11-10 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
WO2015183920A2 (en) 2014-05-28 2015-12-03 Children's Hospital Medical Center Methods and systems for converting precursor cells into gastric tissues through directed differentiation
WO2016061464A1 (en) 2014-10-17 2016-04-21 Children's Hospital Center, D/B/A Cincinnati Children's Hospital Medical Center In vivo model of human small intetine using pluripotent stem cells and methods of making and using same
CN116790476A (zh) 2016-05-05 2023-09-22 儿童医院医疗中心 用于体外制造胃底组织的方法和与其相关的组合物
WO2018106628A1 (en) 2016-12-05 2018-06-14 Children's Hospital Medical Center Colonic organoids and methods of making and using same
EP3635095A4 (en) * 2017-06-09 2021-12-01 Children's Hospital Medical Center LIVER ORGANOID COMPOSITIONS AND METHOD FOR MANUFACTURING AND USING THEREOF
US20210254012A1 (en) * 2018-06-09 2021-08-19 Arizona Board Of Regents On Behalf Of Arizona State University Next generation designer liver organoids and their methods of preparation and use
SG11202102431YA (en) * 2018-09-12 2021-04-29 Childrens Hospital Med Ct Organoid compositions for the production of hematopoietic stem cells and derivatives thereof
AU2019351022A1 (en) * 2018-09-27 2021-04-15 Children's Hospital Medical Center Liver support system comprising liver organoids and methods of making and using same
EP3950931A4 (en) 2019-03-29 2022-11-30 Nagasaki University CULTIVATED TISSUE AND PROCESS OF PRODUCTION
WO2020243613A1 (en) * 2019-05-31 2020-12-03 Children's Hospital Medical Center Methods of generating and expanding hematopoietic stem cells
JP7039045B2 (ja) * 2019-08-26 2022-03-22 株式会社フェニックスバイオ ヒト脂肪肝モデル細胞
JP2023516484A (ja) 2020-03-11 2023-04-19 ビット バイオ リミテッド 肝細胞作製方法
CN113717850A (zh) * 2020-05-26 2021-11-30 中国科学院大连化学物理研究所 一种基于三维类肝芯片的非酒精性脂肪肝体外模型建立方法
WO2021243526A1 (zh) * 2020-06-01 2021-12-09 苏州大学附属儿童医院 新生儿肠外营养相关性肝病特异性标志物lncRNA的应用
WO2021262676A1 (en) * 2020-06-23 2021-12-30 Children's Hospital Medical Center Model for insulin resistance
EP4332215A1 (en) * 2021-04-28 2024-03-06 National University Corporation Tokyo Medical and Dental University Method for producing cells
WO2022236144A1 (en) 2021-05-06 2022-11-10 Massachusetts Institute Of Technology Ex vivo tissue explant and graft platform and uses thereof
CN113430890A (zh) * 2021-07-01 2021-09-24 驻马店市华中公路设计有限公司 用于旧沥青路面改造的永久性复合式路面结构及施工装置
CN115125187B (zh) * 2022-06-14 2023-04-07 创芯国际生物科技(广州)有限公司 一种子宫内膜炎症的类器官体外模型及其建立方法和应用
CN115386535B (zh) * 2022-10-26 2023-02-03 天津外泌体科技有限公司 多谱系肝类器官模型及基于该模型的药物肝毒评价方法
CN115418386B (zh) * 2022-11-03 2023-03-24 成都诺医德医学检验实验室有限公司 一种基于皮肤类器官的损伤愈合评价方法及模型和应用
WO2024185901A1 (ja) * 2023-03-09 2024-09-12 国立大学法人 東京医科歯科大学 脂肪性肝疾患を処置することに用いるための組成物
WO2024206911A2 (en) 2023-03-30 2024-10-03 Children's Hospital Medical Center Clinical-grade organoids

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003050249A2 (en) 2001-12-07 2003-06-19 Geron Corporation Islet cells from human embryonic stem cells
CN103898045B (zh) 2003-12-23 2019-02-01 维亚希特公司 定形内胚层
ES2523591T3 (es) 2006-06-27 2014-11-27 Intercept Pharmaceuticals Inc. Derivados de ácidos biliares como ligandos de FXR para la prevención o el tratamiento de enfermedades o estados mediados por FXR
DE602007012293D1 (ja) * 2006-12-08 2011-03-10 Du Pont
EP2412800A1 (en) * 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
EP2393917B1 (en) 2009-02-03 2016-04-06 Koninklijke Nederlandse Akademie van Wetenschappen Culture medium for epithelial stem cells and organoids comprising said stem cells.
WO2010094694A1 (en) 2009-02-23 2010-08-26 F. Hoffmann-La Roche Ag Assays to predict cardiotoxicity
RU2011139643A (ru) 2009-03-17 2013-04-27 Акскан Фарма, Инк. Способ лечения неалкогольного стеатогепатита повышенными дозами урсодезоксихолевой кислоты
EP2443230B1 (en) * 2009-06-18 2017-07-26 Takara Bio Europe AB 3D CULTURING SYSTEMS FOR GROWTH AND DIFFERENTIATION OF HUMAN PLURIPOTENT STEM (hPS) CELLS
CN101696396A (zh) * 2009-10-27 2010-04-21 中国人民解放军军事医学科学院卫生学环境医学研究所 乙型肝炎病毒体外感染模型的构建方法及应用
WO2011066369A2 (en) * 2009-11-24 2011-06-03 Alder Biopharmaceuticals, Inc. Antagonists of il-6 to raise albumin and/or lower crp
JP5897543B2 (ja) * 2010-03-22 2016-03-30 セルアーティス アーベー Wntシグナル経路の調節による多能性細胞から肝細胞様細胞への分化誘導と成熟
WO2011140441A2 (en) 2010-05-06 2011-11-10 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
US20120291096A1 (en) * 2011-05-12 2012-11-15 Nokia Corporation Method and apparatus for secure signing and utilization of distributed computations
SI3336097T1 (sl) 2012-06-19 2021-07-30 Intercept Pharmaceuticals, Inc. Priprava nekristalinične oblike obetiholne kisline
US20160237400A1 (en) * 2013-03-15 2016-08-18 The Jackson Laboratory Isolation of non-embryonic stem cells and uses thereof
US20160245653A1 (en) 2013-04-30 2016-08-25 Sangtae Park Cylindrical resonator gyroscope
JP6455934B2 (ja) 2013-07-23 2019-01-23 公立大学法人横浜市立大学 生物学的組織に血管系を付与する方法
RU2020119611A (ru) 2014-03-21 2020-06-29 Тобира Терапьютикс, Инк. Сенекривирок для лечения фиброза
MX369921B (es) 2014-04-11 2019-11-26 Cymabay Therapeutics Inc Tratamiento de la hgna y ehna.
WO2015183920A2 (en) * 2014-05-28 2015-12-03 Children's Hospital Medical Center Methods and systems for converting precursor cells into gastric tissues through directed differentiation
CA2950470A1 (en) 2014-06-06 2015-12-10 Vrije Universiteit Brussel Human hepatic 3d co-culture model and uses thereof
IL282156B (en) 2014-07-29 2022-07-01 Shenzhen Hightide Biopharmaceutical Ltd Salts of berberic acid, salts of ursodeoxycholic acid and their combinations, methods for their preparation and their uses
AU2015314830B2 (en) 2014-09-12 2021-01-07 Tobira Therapeutics, Inc. Cenicriviroc combination therapy for the treatment of fibrosis
SG11201701844YA (en) * 2014-10-08 2017-04-27 Agency Science Tech & Res Methods of differentiating stem cells into liver cell lineages
CN104387451B (zh) * 2014-11-07 2020-12-18 浙江海洋学院 一种对非酒精性脂肪肝病细胞模型具有修复作用的文蛤酶解寡肽及其制备方法
CN107208054B (zh) * 2014-11-26 2021-09-17 艾克塞利瑞提德生物技术公司 诱导的肝细胞及其用途
EA201892625A1 (ru) 2015-01-09 2019-07-31 Джилид Аполло, Ллс КОМБИНИРОВАННАЯ ТЕРАПИЯ С ПРИМЕНЕНИЕМ ИНГИБИТОРА АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ (ACC) ДЛЯ ЛЕЧЕНИЯ НЕАЛКОГОЛЬНОЙ ЖИРОВОЙ БОЛЕЗНИ ПЕЧЕНИ
US20160256672A1 (en) * 2015-02-10 2016-09-08 Cedars-Sinai Medical Center Induced pluripotent stem cell-derived hepatocyte based bioartificial liver device
CN105985395A (zh) 2015-02-13 2016-10-05 江苏奥赛康药业股份有限公司 一种奥贝胆酸化合物及含有该化合物的药物组合物
SG10202103552XA (en) 2015-03-09 2021-05-28 Intekrin Therapeutics Inc Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
KR20170132879A (ko) * 2015-04-07 2017-12-04 인터셉트 파마슈티컬즈, 인크. 조합 요법을 위한 약제학적 조성물
US10557124B2 (en) * 2015-04-22 2020-02-11 The Regents Of The University Of Michigan Compositions and methods for obtaining stem cell derived lung tissue, and related uses thereof
PE20180690A1 (es) 2015-04-27 2018-04-23 Intercept Pharmaceuticals Inc Composiciones de acido obeticolico y metodos de uso
BR112017028414B1 (pt) 2015-06-30 2021-09-08 Basf Agro B.V. Arnhem Método de controle de pragas
CN110582564A (zh) * 2015-09-15 2019-12-17 新加坡科技研究局 从人类多能干细胞衍生肝类器官
MX2018003179A (es) 2015-09-16 2018-08-21 Tobira Therapeutics Inc Terapia de combinación con cenicriviroc para el tratamiento de fibrosis.
US10801068B2 (en) 2015-10-16 2020-10-13 The Trustees Of Columbia University In The City Of New York JAG1 expression predicts therapeutic response in NASH
CA3000016A1 (en) 2015-11-06 2017-05-11 Gemphire Therapeutics Inc. Gemcabene combinations for the treatment of cardiovascular disease
EP3426766B1 (en) * 2016-03-08 2022-12-28 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Method for continuous biosensing
EP3228306A1 (en) 2016-04-04 2017-10-11 ratiopharm GmbH Complex compound comprising obeticholic acid and cyclodextrin and pharmaceutical formulation comprising the complex compound
WO2017184586A1 (en) 2016-04-18 2017-10-26 The Trustees Of Columbia University In The City Of New York Therapeutic targets involved in the progression of nonalcoholic steatohepatitis (nash)
AU2017253228B2 (en) 2016-04-22 2020-04-09 Taiwanj Pharmaceuticals Co., Ltd. Nalmefene, naltrexone or derivatives thereof for use in treating (non)-alcoholic steatohepatitis or non-alcoholic fatty liver disease
EP3635095A4 (en) * 2017-06-09 2021-12-01 Children's Hospital Medical Center LIVER ORGANOID COMPOSITIONS AND METHOD FOR MANUFACTURING AND USING THEREOF

Similar Documents

Publication Publication Date Title
JP2019534006A5 (ja)
Yin et al. A 3D human placenta-on-a-chip model to probe nanoparticle exposure at the placental barrier
Ramadan et al. Organ-on-a-chip engineering: Toward bridging the gap between lab and industry
Yu et al. Engineering microfluidic organoid-on-a-chip platforms
Zhang et al. Cancer-on-a-chip systems at the frontier of nanomedicine
Antoni et al. Three-dimensional cell culture: a breakthrough in vivo
MoraesEqual contributions et al. On being the right size: scaling effects in designing a human-on-a-chip
Li et al. Microfluidic organ-on-a-chip system for disease modeling and drug development
Kanabekova et al. Microfluidic organ-on-a-chip devices for liver disease modeling in vitro
Guo et al. The gut–organ-axis concept: Advances the application of gut-on-chip technology
Tan et al. Assessment of tumorigenic potential in mesenchymal-stem/stromal-cell-derived small extracellular vesicles (MSC-sEV)
Lewis-Israeli et al. Heart organoids and engineered heart tissues: Novel tools for modeling human cardiac biology and disease
Dolatshahi-Pirouz et al. Micro-and nanoengineering approaches to control stem cell-biomaterial interactions
Lee et al. The combined effects of co-culture and substrate mechanics on 3D tumor spheroid formation within microgels prepared via flow-focusing microfluidic fabrication
Han et al. Cellular spheroids of mesenchymal stem cells and their perspectives in future healthcare
Andersen et al. Developing microphysiological systems for use as regulatory tools–challenges and opportunities
Baddal et al. Refining host-pathogen interactions: organ-on-chip side of the coin
Panwar et al. 3D hepatic organoid-based advancements in liver tissue engineering
Ma et al. Three-dimensional cell Co-culture liver models and their applications in pharmaceutical research
Donoghue et al. Tissue chips and microphysiological systems for disease modeling and drug testing
Zommiti et al. Organs-on-Chips platforms are everywhere: A zoom on biomedical investigation
Akasov et al. 3D in vitro co-culture models based on normal cells and tumor spheroids formed by cyclic RGD-peptide induced cell self-assembly
Liu et al. Patterned fibers embedded microfluidic chips based on PLA and PDMS for Ag nanoparticle safety testing
Lacombe et al. From organ-on-chip to body-on-chip: The next generation of microfluidics platforms for in vitro drug efficacy and toxicity testing
Guo et al. Fabrication of concave microwells and their applications in micro-tissue engineering: A review